Bert Vogelstein was one of 11 recipients of the first Breakthrough Prize in Life Sciences. He will receive $3 million for his groundbreaking work with cancer genomics and tumor suppressor genes.
Dr. Vogelstein is the director of the Ludwig Center for Cancer Genetics & Therapeutics and professor of oncology and pathology at firm client Johns Hopkins’ Sidney Kimmel Comprehensive Cancer Center. He also serves as an investigator with the Howard Hughes Medical Institute.
Leading entrepreneurs and innovators created the Breakthrough Prize in Life Sciences Foundation, a not-for-profit corporation that will advance research in life sciences, celebrate scientists and promote the pursuit of science as a career. The foundation will continue to award five $3 million prizes to scientists and researchers each year.
Founding members of the foundation include Art Levinson, chairman of Apple and chairman and former CEO of Genentech; Sergey Brin, co-founder of Google; Anne Wojcicki, founder of 23andMe and Brin’s wife; Mark Zuckerberg, founder of Facebook; Priscilla Chan, Zuckerberg’s wife; and Yuri Milner, a Russian entrepreneur.
Dr. Vogelstein has been awarded numerous patents. In fact, his patents are so numerous that when the U.S. Patent and Trademark Office unveiled its Internet database of patents in 1999, it used his patents in its public demonstration.
Banner & Witcoff congratulates Johns Hopkins’ Vogelstein for this extraordinary achievement. Please click here for more information about the foundation and 2013 prize recipients.
Posted: March 4, 2013